Cyclo Therapeutics, Inc. (CYTH)

USD 0.72

(0.0%)

Total Debt Summary of Cyclo Therapeutics, Inc.

  • Cyclo Therapeutics, Inc.'s latest annual total debt in 2023 was 1.03 Million USD , down 0.0% from previous year.
  • Cyclo Therapeutics, Inc.'s latest quarterly total debt in 2024 Q2 was 2.99 Million USD , up 350.62% from previous quarter.
  • Cyclo Therapeutics, Inc. reported annual total debt of - USD in 2022, down -100.0% from previous year.
  • Cyclo Therapeutics, Inc. reported annual total debt of 170.99 Thousand USD in 2021, down -12.06% from previous year.
  • Cyclo Therapeutics, Inc. reported quarterly total debt of 665.06 Thousand USD for 2024 Q1, down -35.63% from previous quarter.
  • Cyclo Therapeutics, Inc. reported quarterly total debt of 53.49 Thousand USD for 2023 Q1, down 0.0% from previous quarter.

Annual Total Debt Chart of Cyclo Therapeutics, Inc. (2023 - 2000)

Historical Annual Total Debt of Cyclo Therapeutics, Inc. (2023 - 2000)

Year Total Debt Total Debt Growth
2023 1.03 Million USD 0.0%
2022 - USD -100.0%
2021 170.99 Thousand USD -12.06%
2020 194.44 Thousand USD 270.29%
2019 52.51 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 754.03 Thousand USD -5.09%
2014 794.49 Thousand USD -6.72%
2013 851.77 Thousand USD -13.62%
2012 986.06 Thousand USD 17.84%
2011 836.8 Thousand USD 90.63%
2010 438.97 Thousand USD 0.0%
2009 - USD 0.0%
2008 - USD -100.0%
2007 161.4 Thousand USD 8.92%
2006 148.18 Thousand USD -6.45%
2005 158.39 Thousand USD -26.2%
2004 214.63 Thousand USD 12.41%
2003 190.94 Thousand USD 18.31%
2002 161.38 Thousand USD -14.71%
2001 189.21 Thousand USD -15.31%
2000 223.43 Thousand USD 0.0%

Peer Total Debt Comparison of Cyclo Therapeutics, Inc.

Name Total Debt Total Debt Difference
Esperion Therapeutics, Inc. 540.94 Million USD 99.809%
Theratechnologies Inc. 58.96 Million USD 98.248%
Safety Shot Inc 1.54 Million USD 33.303%
Cosmos Health Inc. 12.42 Million USD 91.684%
Cronos Group Inc. 2.53 Million USD 59.325%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.856%
Kala Pharmaceuticals, Inc. 36.32 Million USD 97.156%
Organogenesis Holdings Inc. 119.35 Million USD 99.134%
Universe Pharmaceuticals INC 5.48 Million USD 81.156%
ProPhase Labs, Inc. 21.38 Million USD 95.168%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -69.92%
Dynavax Technologies Corporation 256.91 Million USD 99.598%
Radius Health, Inc. 365.31 Million USD 99.717%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 60.977%
Alvotech 1.07 Billion USD 99.904%
Sunshine Biopharma, Inc. 657.7 Thousand USD -57.079%
Alpha Teknova, Inc. 30.45 Million USD 96.608%
Intra-Cellular Therapies, Inc. 16.93 Million USD 93.901%
SCYNEXIS, Inc. 15.08 Million USD 93.149%
Harrow Health, Inc. 190.5 Million USD 99.458%
Biofrontera Inc. 5.39 Million USD 80.865%
DURECT Corporation 20.74 Million USD 95.02%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 97.512%
ANI Pharmaceuticals, Inc. 315.32 Million USD 99.672%
OptiNose, Inc. 131.74 Million USD 99.216%
RedHill Biopharma Ltd. 1.17 Million USD 11.926%
Aquestive Therapeutics, Inc. 98.82 Million USD 98.955%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 94.394%
SIGA Technologies, Inc. 1.46 Million USD 29.432%
Lifecore Biomedical, Inc. 130.36 Million USD 99.207%
Shineco, Inc. 29.65 Million USD 96.516%
Phibro Animal Health Corporation 525.45 Million USD 99.803%
Procaps Group S.A. 285.93 Million USD 99.639%
TherapeuticsMD, Inc. 8 Million USD 87.094%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -1627.415%
Viatris Inc. 18.12 Billion USD 99.994%
Sunshine Biopharma, Inc. 657.7 Thousand USD -57.079%
Rockwell Medical, Inc. 13.43 Million USD 92.313%
Incannex Healthcare Limited 373 Thousand USD -176.975%
Aytu BioPharma, Inc. 15.12 Million USD 93.171%
Tilray Brands, Inc. 387.31 Million USD 99.733%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.847%
PetIQ, Inc. 468.3 Million USD 99.779%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.759%
Journey Medical Corporation 17.73 Million USD 94.173%
Alimera Sciences, Inc. 67.39 Million USD 98.467%
Petros Pharmaceuticals, Inc. 8.27 Million USD 87.518%
Assertio Holdings, Inc. 40.91 Million USD 97.475%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD 5.018%
Embecta Corp. 1.63 Billion USD 99.937%
Procaps Group, S.A. 285.93 Million USD 99.639%
PainReform Ltd. 86 Thousand USD -1101.297%
Avadel Pharmaceuticals plc 35.38 Million USD 97.08%
Hempacco Co., Inc. 13.72 Million USD 92.472%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 99.824%
Alvotech 1.07 Billion USD 99.904%
Lantheus Holdings, Inc. 616.94 Million USD 99.833%
Kamada Ltd. 8.74 Million USD 88.192%
Indivior PLC 281.6 Million USD 99.633%
Currenc Group, Inc. 31.94 Million USD 96.766%
Evoke Pharma, Inc. 5 Million USD 79.338%
Flora Growth Corp. 3.67 Million USD 71.865%
Cyclo Therapeutics, Inc. 1.03 Million USD 0.0%
Evolus, Inc. 126.54 Million USD 99.184%
HUTCHMED (China) Limited 86.13 Million USD 98.801%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.834%
Akanda Corp. 3.99 Million USD 74.164%